FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17541311000001102: Reboxetine 4mg tablets 20 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Aug 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60628001000001116 Reboxetine 4mg tablets 20 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60628101000001115 Reboxetine 4mg tablets 20 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reboxetine 4mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has VMP Reboxetine 4mg tablets true Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has VMP Reboxetine 4mg tablets false Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has specific active ingredient Reboxetine mesilate true Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has VMP Product containing precisely reboxetine 4 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has specific active ingredient Reboxetine mesilate false Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Reboxetine false Inferred relationship Existential restriction modifier
Reboxetine 4mg tablets 20 tablet Has basis of strength substance Reboxetine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Edronax 4mg tablets (Sigma Pharmaceuticals Plc) 20 tablet Is a True Reboxetine 4mg tablets 20 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start